Literature DB >> 12559283

Influence of age, anthropometry, and hepatic and renal function on serum prostate-specific antigen levels in healthy middle-age men.

J a Hyeon Ku1, Min Eui Kim, Nam Kyu Lee, Young H o Park, Jae Ouk Ahn.   

Abstract

OBJECTIVES: To test the hypothesis of a causal relationship between clinical parameters, including age, anthropometry, and hepatic or renal function tests and serum prostate-specific antigen (PSA) levels and to determine the predictors of high serum PSA concentrations in healthy middle-age men.
METHODS: Between January 1999 and December 2000, 6005 healthy men 40 to 59 years old who visited our hospital for a routine health checkup were entered into the study. The association between the clinical parameters and a high serum PSA level (greater than 2.5, 3.0, 3.5, or 4.0 ng/mL) was studied in three groups: the 10% with low clinical parameters, the 10% with high clinical parameters, and the remainder as a reference group.
RESULTS: The univariate logistic regression analysis indicated that high or low age, body weight, body mass index, creatinine, and creatinine clearance were significant factors in relation to serum PSA concentration compared with the reference group. In the multivariate model used, only older age was positively related to the serum PSA concentration.
CONCLUSIONS: The results of anthropometry and hepatic and renal function tests do not influence the serum PSA level in this population. Our findings suggest that serum PSA may be a reliable marker in middle-age men without severe hepatic or renal disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12559283     DOI: 10.1016/s0090-4295(02)02001-0

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  14 in total

1.  The likelihood of having a serum PSA level of ≥2.5 ng/mL according to the degree of fatty liver disease in a screened population.

Authors:  Jong Hyun Yoon; Hee Jo Yang; Jae Heon Kim; Seung Whan Doo; Won Jae Yang; Jiyoung Hwang; Seong Sook Hong; Suyeon Park; Dae Yeon Cho
Journal:  Can Urol Assoc J       Date:  2015-12-14       Impact factor: 1.862

2.  Association Between Serum Testosterone and Serum PSA Among Men With and Without Partial Androgen Deficiency.

Authors:  A Shukla; B Sharda; S Sharma; S Bhardwaj; U Kailash; R Kalani; L Satyanarayana; A Shrivastava
Journal:  Indian J Clin Biochem       Date:  2018-07-31

3.  Association between serum prostate-specific antigen level and diabetes, obesity, hypertension, and the laboratory parameters related to glucose tolerance, hepatic function, and lipid profile: implications for modification of prostate-specific antigen threshold.

Authors:  Minoru Kobayashi; Tomoya Mizuno; Hideo Yuki; Tsunehito Kambara; Hironori Betsunoh; Akinori Nukui; Hideyuki Abe; Yoshitatsu Fukabori; Masahiro Yashi; Takao Kamai
Journal:  Int J Clin Oncol       Date:  2019-08-22       Impact factor: 3.402

4.  Effects of obesity on lower urinary tract symptoms in Korean BPH patients.

Authors:  Seung Hwan Lee; Joon Chul Kim; Ji-Youl Lee; Jang Hwan Kim; Cheol Young Oh; Seung Wook Lee; Se Jeong Yoo; Byung Ha Chung
Journal:  Asian J Androl       Date:  2009-09-21       Impact factor: 3.285

5.  Has blood volume an impact on serum PSA levels?

Authors:  Anton Ponholzer; Christian Temml; Stephan Madersbacher
Journal:  World J Urol       Date:  2009-08-27       Impact factor: 4.226

6.  Associations of lifestyle and physiologic factors with prostate-specific antigen concentrations: evidence from the National Health and Nutrition Examination Survey (2001-2004).

Authors:  Niyati Parekh; Yong Lin; Stephen Marcella; Ashima K Kant; Grace Lu-Yao
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-09       Impact factor: 4.254

7.  Serum creatinine and prostate cancer risk in a prospective study.

Authors:  Stephanie J Weinstein; Katrina Mackrain; Rachael Z Stolzenberg-Solomon; Jacob Selhub; Jarmo Virtamo; Demetrius Albanes
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-09-15       Impact factor: 4.254

Review 8.  Body composition and serum prostate-specific antigen: review and findings from Flint Men's Health Study.

Authors:  Jennifer L Beebe-Dimmer; Gary J Faerber; Hal Morgenstern; David Werny; Kirk Wojno; Bronwen Halstead-Nussloch; Kathleen A Cooney
Journal:  Urology       Date:  2008-03-04       Impact factor: 2.649

9.  [Referral criteria for benign prostatic hyperplasia in primary care].

Authors:  José María Molero; David Pérez Morales; Francisco José Brenes Bermúdez; Esperanza Naval Pulido; Antonio Fernández-Pro; Juan Antonio Martín; Jesús Castiñeiras Fernández; José Manuel Cozar Olmo
Journal:  Aten Primaria       Date:  2009-11-14       Impact factor: 1.137

10.  Obesity is a significant risk factor for prostate cancer at the time of biopsy.

Authors:  Stephen J Freedland; Joanne Wen; Melanie Wuerstle; Amy Shah; Dominic Lai; Bita Moalej; Christina Atala; William J Aronson
Journal:  Urology       Date:  2008-08-22       Impact factor: 2.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.